CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH The investigational combination therapy of extended-release pramipexole and extended-release rasagiline controlled symptoms similar to pramipexole alone in this phase 3 trial, but with less sleepiness and orthostatic hypotension. Pramipexole mimics dopamine activity in the brain, and rasagiline increases dopamine levels by blocking dopamine reuptake.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
